StockWatch
·
Biotechnology: Pharmaceutical Preparations
Corporate ActionJul 2, 2026, 04:14 PM

Abivax Prices 6.4M ADSs at $125, Expects $759.8M Net Proceeds

AI Summary

Abivax S.A. entered into an Underwriting Agreement for a public offering of 6,400,000 American Depositary Shares (ADSs) at a price of $125.00 per ADS. The company anticipates receiving approximately $759.8 million (€666.8 million) in net proceeds from the offering, after accounting for underwriting discounts and estimated expenses. The transaction is expected to finalize on July 6, 2026, pending customary closing conditions.

Key Highlights

  • Abivax entered an Underwriting Agreement for a public offering of ADSs.
  • Offering involves 6,400,000 American Depositary Shares (ADSs).
  • Public offering price set at $125.00 per ADS.
  • Expected net proceeds to the company are $759.8 million (€666.8 million).
  • Offering is expected to close on July 6, 2026.